These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17967052)

  • 1. Emergence of recombinant forms of HIV: dynamics and scaling.
    Suryavanshi GW; Dixit NM
    PLoS Comput Biol; 2007 Oct; 3(10):2003-18. PubMed ID: 17967052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV dynamics with multiple infections of target cells.
    Dixit NM; Perelson AS
    Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8198-203. PubMed ID: 15928092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timing the emergence of resistance to anti-HIV drugs with large genetic barriers.
    Arora P; Dixit NM
    PLoS Comput Biol; 2009 Mar; 5(3):e1000305. PubMed ID: 19282958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombination and drug resistance in HIV: population dynamics and stochasticity.
    Kouyos RD; Fouchet D; Bonhoeffer S
    Epidemics; 2009 Mar; 1(1):58-69. PubMed ID: 21352751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased burst size in multiply infected cells can alter basic virus dynamics.
    Cummings KW; Levy DN; Wodarz D
    Biol Direct; 2012 May; 7():16. PubMed ID: 22569346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of recombination for HIV diversity.
    Ramirez BC; Simon-Loriere E; Galetto R; Negroni M
    Virus Res; 2008 Jun; 134(1-2):64-73. PubMed ID: 18308413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of recombination for the coevolutionary dynamics of HIV and the immune response.
    Mostowy R; Kouyos RD; Fouchet D; Bonhoeffer S
    PLoS One; 2011 Feb; 6(2):e16052. PubMed ID: 21364750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of genotypic resistance to antiretroviral drugs in treatment-naive youths infected with diverse HIV type 1 subtypes and recombinant forms in Dar es Salaam, Tanzania.
    Mosha F; Urassa W; Aboud S; Lyamuya E; Sandstrom E; Bredell H; Williamson C
    AIDS Res Hum Retroviruses; 2011 Apr; 27(4):377-82. PubMed ID: 20954839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombination increases human immunodeficiency virus fitness, but not necessarily diversity.
    Vijay NNV; Vasantika ; Ajmani R; Perelson AS; Dixit NM
    J Gen Virol; 2008 Jun; 89(Pt 6):1467-1477. PubMed ID: 18474563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of HIV-1 coinfection in different susceptible target cell populations during cell-free infection.
    Ito Y; Tauzin A; Remion A; Ejima K; Mammano F; Iwami S
    J Theor Biol; 2018 Oct; 455():39-46. PubMed ID: 30018001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombination rate and selection strength in HIV intra-patient evolution.
    Neher RA; Leitner T
    PLoS Comput Biol; 2010 Jan; 6(1):e1000660. PubMed ID: 20126527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling dynamics of acute HIV infection incorporating density-dependent cell death and multiplicity of infection.
    Mainou E; Ribeiro RM; Conway JM
    PLoS Comput Biol; 2024 Jun; 20(6):e1012129. PubMed ID: 38848426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombination Enhances HIV-1 Envelope Diversity by Facilitating the Survival of Latent Genomic Fragments in the Plasma Virus Population.
    Immonen TT; Conway JM; Romero-Severson EO; Perelson AS; Leitner T
    PLoS Comput Biol; 2015 Dec; 11(12):e1004625. PubMed ID: 26693708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quasispecies dynamics and the emergence of drug resistance during zidovudine therapy of HIV infection.
    Frost SD; McLean AR
    AIDS; 1994 Mar; 8(3):323-32. PubMed ID: 7913327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV recombination: what is the impact on antiretroviral therapy?
    Fraser C
    J R Soc Interface; 2005 Dec; 2(5):489-503. PubMed ID: 16849208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics.
    Guedj J; Neumann AU
    J Theor Biol; 2010 Dec; 267(3):330-40. PubMed ID: 20831874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stochastic Dynamics of the Latently Infected Cell Reservoir During HIV Infection.
    Azoz SA; Coombs D
    Bull Math Biol; 2019 Jan; 81(1):131-154. PubMed ID: 30298198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of minor drug-resistant populations by parallel allele-specific sequencing.
    Cai F; Chen H; Hicks CB; Bartlett JA; Zhu J; Gao F
    Nat Methods; 2007 Feb; 4(2):123-5. PubMed ID: 17206150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simple mathematical models do not accurately predict early SIV dynamics.
    Noecker C; Schaefer K; Zaccheo K; Yang Y; Day J; Ganusov VV
    Viruses; 2015 Mar; 7(3):1189-217. PubMed ID: 25781919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.